BioMed Research International

Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease

Characterization of an Artificial Liver Support System-Related Vasovagal Reaction

Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis

The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis

A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B

Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis

Biliary Microbiota and Bile Acid Composition in Cholelithiasis

Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty’s Syndrome: A Case Report and Literature Review

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis

No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis

Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma In Vivo and In Vitro

CCNB2, TOP2A, and ASPM Reflect the Prognosis of Hepatocellular Carcinoma, as Determined by Weighted Gene Coexpression Network Analysis

Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis

Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome

BioMed Research International

Table of Contents

Table of Contents

Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease

Characterization of an Artificial Liver Support System-Related Vasovagal Reaction

Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis

The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis

A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B

Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis

Biliary Microbiota and Bile Acid Composition in Cholelithiasis

Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty’s Syndrome: A Case Report and Literature Review

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis

No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis

Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma In Vivo and In Vitro

CCNB2, TOP2A, and ASPM Reflect the Prognosis of Hepatocellular Carcinoma, as Determined by Weighted Gene Coexpression Network Analysis

Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis

Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome